Clinical Trial Update: PACAP27 Headache Properties in Migraine Without Aura Patients [NA]

View source ↗

Summary

A clinical trial examining PACAP27's headache properties in patients with migraine without aura has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Without Aura

Drugs mentioned

• PACAP27 (pituitary adenylate cyclase-activating polypeptide 27)

Snippet

Sponsor: Danish Headache Center | Conditions: Migraine Without Aura | NA | Status: COMPLETED